Lexicon Pharmaceuticals LXRX Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's accumulated depreciation?
- Lexicon Pharmaceuticals (LXRX) reported accumulated depreciation of $2.82M in Q1 2026.
- How has Lexicon Pharmaceuticals's accumulated depreciation changed year-over-year?
- Lexicon Pharmaceuticals's accumulated depreciation increased by 24.5% year-over-year, from $2.26M to $2.82M.
- What is the long-term trend for Lexicon Pharmaceuticals's accumulated depreciation?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's accumulated depreciation has grown at a -14.2% compound annual growth rate (CAGR), from $5.82M to $2.71M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.